Luís Belo

Author PubWeight™ 32.96‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Serum levels of VEGF and TNF-alpha and their association with C-reactive protein in patients with endometriosis. Arch Gynecol Obstet 2005 1.10
2 Inflammatory disturbances in preeclampsia: relationship between maternal and umbilical cord blood. J Pregnancy 2012 1.02
3 Hepcidin serum levels and resistance to recombinant human erythropoietin therapy in haemodialysis patients. Acta Haematol 2009 0.99
4 Inflammation, T-cell phenotype, and inflammatory cytokines in chronic kidney disease patients under hemodialysis and its relationship to resistance to recombinant human erythropoietin therapy. J Clin Immunol 2008 0.97
5 Leukocyte Count versus C-Reactive Protein Levels in Obese Portuguese Patients Aged 6-12 Years Old. Open Biochem J 2010 0.91
6 Neutrophil activation and resistance to recombinant human erythropoietin therapy in hemodialysis patients. Am J Nephrol 2008 0.89
7 Neutrophil and monocyte activation in chronic kidney disease patients under hemodialysis and its relationship with resistance to recombinant human erythropoietin and to the hemodialysis procedure. Hemodial Int 2010 0.88
8 Lipid profile in Portuguese obese children and adolescents: interaction of apolipoprotein E polymorphism with adiponectin levels. Arch Pediatr Adolesc Med 2009 0.88
9 Erythrocyte damage and leukocyte activation in ischemic stroke. Clin Chim Acta 2002 0.88
10 Erythrocyte membrane protein destabilization versus clinical outcome in 160 Portuguese Hereditary Spherocytosis patients. Br J Haematol 2010 0.87
11 Presence of cytosolic peroxiredoxin 2 in the erythrocyte membrane of patients with hereditary spherocytosis. Blood Cells Mol Dis 2008 0.87
12 Body mass index and resistance to recombinant human erythropoietin therapy in maintenance hemodialysis patients. Ren Fail 2013 0.86
13 Role of prohepcidin, inflammatory markers and iron status in resistance to rhEPO therapy in hemodialysis patients. Am J Nephrol 2008 0.85
14 Erythropoietin promotes deleterious cardiovascular effects and mortality risk in a rat model of chronic sports doping. Cardiovasc Toxicol 2009 0.85
15 Cardiovascular risk factors in portuguese obese children and adolescents: impact of small reductions in body mass index imposed by lifestyle modifications. Open Biochem J 2012 0.85
16 Effects of olive oil polyphenols on erythrocyte oxidative damage. Mol Nutr Food Res 2009 0.83
17 Effects of chitooligosaccharides on human red blood cell morphology and membrane protein structure. Biomacromolecules 2008 0.83
18 Complementary markers for the clinical severity classification of hereditary spherocytosis in unsplenectomized patients. Blood Cells Mol Dis 2010 0.82
19 Circulating cell-free DNA levels in hemodialysis patients and its association with inflammation, iron metabolism, and rhEPO doses. Hemodial Int 2013 0.82
20 Fetal and maternal angiogenic/anti-angiogenic factors in normal and preeclamptic pregnancy. Growth Factors 2009 0.81
21 Are we employing the most effective CA 125 and CA 19-9 cut-off values to detect endometriosis? Eur J Obstet Gynecol Reprod Biol 2005 0.81
22 Relationship between maternal and cord blood hemostatic disturbances in preeclamptic pregnancies. Thromb Res 2008 0.81
23 Oxidized low-density lipoprotein and lipoprotein(a) levels in chronic kidney disease patients under hemodialysis: influence of adiponectin and of a polymorphism in the apolipoprotein(a) gene. Hemodial Int 2012 0.80
24 Circulating levels of adiponectin, oxidized LDL and C-reactive protein in Portuguese patients with psoriasis vulgaris, according to body mass index, severity and duration of the disease. J Dermatol Sci 2009 0.80
25 Changes in red blood cells membrane protein composition during hemodialysis procedure. Ren Fail 2008 0.79
26 Recombinant human erythropoietin treatment protects the cardio-renal axis in a model of moderate chronic renal failure. Ren Fail 2010 0.79
27 Haemostatic factors in women with history of preeclampsia. Thromb Res 2008 0.79
28 Erythrocyte changes in preeclampsia: relationship between maternal and cord blood erythrocyte damage. J Perinat Med 2009 0.79
29 Oxidized-LDL levels in normal and pre-eclamptic pregnancies: contribution of LDL particle size. Atherosclerosis 2005 0.78
30 Lipoprotein(a): a longitudinal versus a cross-sectional study in normal pregnancy and its levels in preeclampsia. Atherosclerosis 2002 0.78
31 Main determinants of PON1 activity in hemodialysis patients. Am J Nephrol 2012 0.78
32 DMT1 (NRAMP2/DCT1) genetic variability and resistance to recombinant human erythropoietin therapy in chronic kidney disease patients under haemodialysis. Acta Haematol 2008 0.77
33 Adhesion molecules (VCAM-1 and ICAM-1) and C-reactive protein in women with history of preeclampsia. Acta Obstet Gynecol Scand 2008 0.77
34 Psoriasis therapy and cardiovascular risk factors: a 12-week follow-up study. Am J Clin Dermatol 2010 0.77
35 Altered erythrocyte membrane protein composition in chronic kidney disease stage 5 patients under haemodialysis and recombinant human erythropoietin therapy. Blood Purif 2008 0.77
36 Erythroid disturbances before and after treatment of Portuguese psoriasis vulgaris patients: a cross-sectional and longitudinal study. Am J Clin Dermatol 2012 0.76
37 Major determinants of BMP-2 serum levels in hemodialysis patients. Ren Fail 2012 0.76
38 Hereditary spherocytosis and the (TA)nTAA polymorphism of UGT1A1 gene promoter region--a comparison of the bilirubin plasmatic levels in the different clinical forms. Blood Cells Mol Dis 2010 0.76
39 Altered alanine aminotransferase and gamma-glutamyl transpeptidase in women with history of preeclampsia: association with waist-to-hip ratio and body mass index. Eur J Gastroenterol Hepatol 2009 0.76
40 Comparison of Bio-Plex measurements with standard techniques. Clin Chem Lab Med 2011 0.76
41 Enhanced thrombotic risk in pregnancy and postpartum: association with CRP elevation? Am J Obstet Gynecol 2006 0.75
42 Letter to the editor: A potential mechanism for the pathogenesis of psoriasis vulgaris. Int J Dermatol 2012 0.75
43 IL-7 serum levels and lymphopenia in hemodialysis patients, non-responders to recombinant human erythropoietin therapy. Blood Cells Mol Dis 2008 0.75
44 Adiponectin is an independent predictor of tissue plasminogen activator levels in patients under haemodialysis. Scand J Urol Nephrol 2012 0.75
45 Principal determinants of the length of remission of psoriasis vulgaris after topical, NB-UVB, and PUVA therapy: a follow-up study. Am J Clin Dermatol 2013 0.75
46 Linkage of cytosolic peroxiredoxin 2 to erythrocyte membrane imposed by hydrogen peroxide-induced oxidative stress. Blood Cells Mol Dis 2009 0.75
47 Vascular access versus the effect of statins on inflammation and fibrinolysis in renal dialysis patients. J Vasc Access 2013 0.75
48 Elastase release during the hemodialysis procedure seems to induce changes in red blood cell membrane proteins. Hemodial Int 2011 0.75
49 Erythropoiesis versus inflammation in Hereditary Spherocytosis clinical outcome. Clin Biochem 2011 0.75